| Product NDC: | 0228-2069 |
| Proprietary Name: | Oxazepam |
| Non Proprietary Name: | Oxazepam |
| Active Ingredient(s): | 15 mg/1 & nbsp; Oxazepam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, GELATIN COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0228-2069 |
| Labeler Name: | Actavis Elizabeth LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA072252 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070102 |
| Package NDC: | 0228-2069-50 |
| Package Description: | 500 CAPSULE, GELATIN COATED in 1 BOTTLE (0228-2069-50) |
| NDC Code | 0228-2069-50 |
| Proprietary Name | Oxazepam |
| Package Description | 500 CAPSULE, GELATIN COATED in 1 BOTTLE (0228-2069-50) |
| Product NDC | 0228-2069 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Oxazepam |
| Dosage Form Name | CAPSULE, GELATIN COATED |
| Route Name | ORAL |
| Start Marketing Date | 20070102 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Elizabeth LLC |
| Substance Name | OXAZEPAM |
| Strength Number | 15 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |